Rarebase
we are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel. with data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. our drug-gene atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. our proprietary artificial intelligence modeling suite, conductor ai, used our drug-gene atlas to discover and predict the effects of new drugs at transcriptome scale.
Last updated on
About Rarebase
Founded
2020Employees
11-50Funding / Mkt. Cap
$10MCategory
Industry
PharmaceuticalsLocation
City
Palo AltoState
CaliforniaCountry
United StatesRarebase
Find your buyer within Rarebase